Menu Menu

TBPH    Theravance Biopharma Inc    1583107    
Income Statement
Revenue 16,868,000
Net Income -12,698,000
Profit Margin -75.28%

Balance Sheet
Current Assets 116,480,000
Assets 356,105,000
Current Liabilities 23,435,000
Liabilities 170,451,000
Equity 185,654,000
Shares Out 48,922,000

Cash Flow Statement
Operating Cash Flow -10,633,000
Investing Cash Flow -3,402,000

Market Analysis
Market Cap 423,175,886
Price 8.58
BVPS 3.79
PB 2.26
EPS -0.92
PS 6.27
FCF -14,035,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/26 -0.17
Apr May Jun
5/13 -0.24
Jul Aug Sep
8/05 -0.34
Oct Nov Dec
11/04

Find a discrepancy? The most accurate way to find company fundamental data is to view TBPH documents filed with the SEC.


TBPH Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: